This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Pediatric Femur Fracture Registry (PedFemFx)

This study is not yet open for participant recruitment.
See Contacts and Locations
Verified July 2017 by AO Clinical Investigation and Documentation
Sponsor:
Information provided by (Responsible Party):
AO Clinical Investigation and Documentation
ClinicalTrials.gov Identifier:
NCT03211546
First received: July 6, 2017
Last updated: July 7, 2017
Last verified: July 2017
  Purpose
Prospective data collection and evaluation of complete data sets will be performed in the course of routine clinical care of a cohort of consecutive patients (children up to 16 years old) presenting with an isolated femur shaft fracture. Data will be collected during follow-up visits at 3 to 6 weeks, 3, 6, 12 and 24 months, with additional follow-up visits as needed or dictated by individual practice. Final follow-up will be at 24 months, unless a patient requires additional follow-up or another intervention to address an unfavorable outcome (e.g. malalignment, nonunion, limb length discrepancy) noted at the 24 month follow-up visit.

Condition Intervention
Femoral Shaft Fracture Procedure: Conservative (non-surgical) treatment Procedure: Surgical treatment

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 24 Months
Official Title: A Prospective Multicenter Observational Registry for Femoral Shaft Fractures in Children up to 16 Years of Age

Resource links provided by NLM:


Further study details as provided by AO Clinical Investigation and Documentation:

Primary Outcome Measures:
  • Fracture alignment [ Time Frame: up to 24 months ]
    Mechanical and anatomical axes


Secondary Outcome Measures:
  • Range of Motion (ROM) [ Time Frame: up to 24 months ]
    ROM of the hip (flexion/extension, internal/external rotation and abduction/adduction) and the knee (flexion/extension)

  • Axial deviation [ Time Frame: up to 24 months ]
    Varus/valgus malalignment, flexion/extension deficit or rotational malalignment will be evaluated compared to the contralateral (healthy) leg

  • Leg Length Discrepancy [ Time Frame: up to 24 months ]
    The Leg Length Discrepancy (LLD) will be measured using the standing blocks method

  • Quadriceps strength [ Time Frame: up to 24 months ]
    The quadriceps strength will be measure using the manual muscle testing.

  • Return to full activity [ Time Frame: up to 24 months ]
    ime to full weight-bearing, time to full activity, and time to return to kindergarten/school.

  • Patient-reported outcome [ Time Frame: up to 24 months ]
    Patient Reported Outcomes of Fracture Healing- Lower Limb

  • Health Related Quality of Life [ Time Frame: up to 24 months ]
    EQ-5D-Y version proxy 1


Estimated Enrollment: 200
Anticipated Study Start Date: October 2017
Estimated Study Completion Date: April 2022
Estimated Primary Completion Date: December 2021 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Femoral shaft fracture
Patients (children up to 16 years old) diagnosis of isolated closed femur shaft fracture (3.2-D) and open distal physis. Treatment strategies will follow standard of care (routine) procedures, either conservative (non-surgical) treatment or surgical treatment.
Procedure: Conservative (non-surgical) treatment
Spica cast Traction Traction and spica cast
Procedure: Surgical treatment
Elastic Stable Intramedullary Nailing (ESIN) Conventional locking intramedullary nail Plating External fixation

Detailed Description:

There is limited evidence about the comparative effectiveness of different treatments for pediatric femur fractures. The most common method used for isolated femur shaft fractures of children older than 5 years of age is elastic stable intramedullary nailing (ESIN). It is thought to be the ideal indication for children up to the age of 10 to 12 and it is the most commonly employed method of internal fixation in this age group, but other treatments include external fixation, plating, other forms of flexible or rigid intramedullary nailing and non-operative options such as spica casts or traction. In children under the age of 5 non-operative methods are believed to work well with few complications. Imperfect alignment is more acceptable because of the tremendous remodelling potential in young growing children. Internal fixation is believed to be unnecessary as it is more invasive, with some risk of complications and likely need for a second surgical procedure to remove it. Biomechanical properties are different in this age group. Consequently, operative treatment of these fractures is generally not recommended in children under the age of 3 according to the German guidelines (www.awmf.org), not under the age of 5 in the American guidelines (www.aaos.org); and in Great Britain, surgical management in preschool children is restricted to polytrauma and complex injuries (www.nice.org.uk).

Despite these recommendations and the general acceptance of non-operative treatment for younger children , a survey of clinical practice in Germany revealed that 50% of children under the age of 3 years are treated with ESIN, because some surgeons believe that patients seem less comfortable when treated with traction or spica casting and might experience a higher rate of loss of reduction. Consequently, the use of ESIN for fractures in preschool children has become more prevalent in the last years.

Similarly, there is wide variation in the preferred management of femoral shaft fractures in older children, with little evidence about the comparative effectiveness of different treatments for pediatric femur fractures. There is an imperative to collect prospective data to generate higher quality evidence.

The purpose of this proposed registry is to collect the clinical outcomes (fracture healing & patient reported outcomes and complications) of the treatment of isolated femur shaft fractures in children up to skeletal maturity. Additionally, health economic aspects will be evaluated to give possible recommendations from a health economic perspective.

  Eligibility

Ages Eligible for Study:   up to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Consecutive patients (children up to 16 years old) presenting with an isolated closed femur shaft fracture (3.2-D) and open distal physis.
Criteria

Inclusion Criteria:

  • Age less than 16 years of age at the time of the injury
  • Open distal physis of the femur
  • Diagnosis of isolated closed femur shaft fracture (3.2-D)
  • Willingness and ability of the patient/parents/legally responsible care giver to participate in the clinical investigation including imaging and FU procedures as standard of care in each clinic
  • Willingness and ability of the parent(s) to support the patient in his/her study participation
  • Ability of parents to understand the content of the patient information / ICF and participation in the clinical investigation
  • Signed ICF by patient and/or parent(s) according to local policies and regulations

Exclusion Criteria:

  • Polytraumatized patient
  • Closed distal physis of the femur
  • Pathologic fractures and fractures in patients with metabolic bone disease, osteogenesis imperfecta, neuromuscular disorder, endocrinologic disease or other conditions influencing the bony structure
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT03211546

Contacts
Contact: Víctor Díaz, PhD 0041814142507 victor.diaz@aofoundation.org
Contact: Andreas Faeh, MSc andreas.faeh@aofoundation.org

Locations
United States, Massachusetts
Boston Children's Hospital Not yet recruiting
Boston, Massachusetts, United States, 02115
Contact: Ben Shore, Dr.         
Austria
Medical University Hospital of Graz Not yet recruiting
Graz, Austria, 8036
Contact: Holger Till, Prof.         
Canada, British Columbia
BC Children's Hospital Not yet recruiting
Vancouver, British Columbia, Canada, V6H 3V4
Contact: Kishore Mulpuri, Dr.         
Canada, New Scotland
IWK Health Centre Not yet recruiting
Halifax, New Scotland, Canada, B3K-6R8
Contact: Ron El-Hawary, Dr.         
Canada, Ontario
Children's Hospital of Eastern Ontario (CHEO) Not yet recruiting
Ottawa, Ontario, Canada, K1H 8L1
Contact: Sasha Carsen, Dr.         
The Hospital for Sick Children Not yet recruiting
Toronto, Ontario, Canada, M5P3E1
Contact: Unni G. Narayanan, Prof.         
Germany
Universitätsklinik Dresden Not yet recruiting
Dresden, Germany, 1307
Contact: Philipp Schwerk, Dr.         
University Medicine Göttingen (UMG) Not yet recruiting
Göttingen, Germany, 37075
Contact: Klaus Dresing, Dr.         
Altonaer Kinderkrankenhaus gGmbH Not yet recruiting
Hamburg, Germany, 22763
Contact: Dirk Sommerfeldt, Dr.         
Städt. Klinikum Karlsruhe Not yet recruiting
Karlsruhe, Germany, 76133
Contact: Schmittenbecher Peter, Prof.         
University of Leipzig Not yet recruiting
Leipzig, Germany, 4103
Contact: Roland Boehm         
University Hospital Tübingen Not yet recruiting
Tübingen, Germany, 72070
Contact: Justus Lieber         
Switzerland
Inselspital Not yet recruiting
Bern, Switzerland, 3010
Contact: Steffen Berger, Dr.         
Childrens Hospital Zurich Not yet recruiting
Zürich, Switzerland, 8032
Contact: Christoph Aufdenblatten, Dr.         
Sponsors and Collaborators
AO Clinical Investigation and Documentation
Investigators
Principal Investigator: Peter P. Schmittenbecher, Prof. Kinderchirurgische Klinik, Klinikum Karlsruhe
Principal Investigator: Unni G. Narayanan, Prof. The Hospital for Sick Children, Toronto
  More Information

Responsible Party: AO Clinical Investigation and Documentation
ClinicalTrials.gov Identifier: NCT03211546     History of Changes
Other Study ID Numbers: RP_PedFemFx_1.0
Study First Received: July 6, 2017
Last Updated: July 7, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by AO Clinical Investigation and Documentation:
Pediatric femur fracture
Spica casting
Traction
Intramedullary nailing
Children
Internal fixation
External fixation

Additional relevant MeSH terms:
Fractures, Bone
Femoral Fractures
Wounds and Injuries
Leg Injuries

ClinicalTrials.gov processed this record on July 11, 2017